Apotea (APOTEA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Apotea (APOTEA) has a cash flow conversion efficiency ratio of 0.080x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr76.80 Million ≈ $8.26 Million USD) by net assets (Skr962.80 Million ≈ $103.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Apotea (APOTEA) market capitalisation for the company's overall valuation and market capitalisation.
Apotea - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how Apotea's cash flow conversion efficiency has evolved over time, based on yearly financial data. View APOTEA live share price for real-time trading data and today's change.
Apotea Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Apotea ranked by their cash flow conversion efficiency. Review APOTEA FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Berliner Effektengesellschaft AG
F:BFV
|
N/A |
|
Suzhou Chunqiu Electronic Technology Co Ltd Class A
SHG:603890
|
0.028x |
|
TPK Holding Co Ltd
TW:3673
|
-0.008x |
|
Motic Xiamen Electric Group Co Ltd
SHE:300341
|
0.010x |
|
Astra Otoparts Tbk
JK:AUTO
|
0.045x |
|
Healthcare Global Enterprises Limited
NSE:HCG
|
0.136x |
|
Uniphar Group PLC
IR:UPR
|
-0.017x |
|
YCC CORP
KQ:232140
|
0.072x |
Annual Cash Flow Conversion Efficiency for Apotea (2021–2025)
The table below shows the annual cash flow conversion efficiency of Apotea from 2021 to 2025. Also see total assets of Apotea for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr859.90 Million ≈ $92.54 Million |
Skr333.30 Million ≈ $35.87 Million |
0.388x | -89.24% |
| 2024-12-31 | Skr57.24 Million ≈ $6.16 Million |
Skr206.20 Million ≈ $22.19 Million |
3.602x | -29.83% |
| 2023-12-31 | Skr42.04 Million ≈ $4.52 Million |
Skr215.80 Million ≈ $23.22 Million |
5.133x | +5685.32% |
| 2022-12-31 | Skr355.00 Million ≈ $38.20 Million |
Skr31.50 Million ≈ $3.39 Million |
0.089x | -86.74% |
| 2021-12-31 | Skr339.76 Million ≈ $36.56 Million |
Skr227.30 Million ≈ $24.46 Million |
0.669x | -- |
About Apotea
Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, baby, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food … Read more